Edition:
United States

People: Immunomedics Inc (IMMU.OQ)

IMMU.OQ on NASDAQ Stock Exchange Global Market

18.80USD
4:00pm EDT
Change (% chg)

$-0.04 (-0.21%)
Prev Close
$18.84
Open
$18.86
Day's High
$18.96
Day's Low
$18.39
Volume
528,591
Avg. Vol
926,884
52-wk High
$27.32
52-wk Low
$11.57

Delaney, Brendan 

Mr. Brendan P. Delaney is Chief Commercial Officer of the Company. Mr. Brendan was most recently Vice President, U.S. Commercial Hematology Oncology at Celgene. In this role, Brendan oversaw a team of roughly 400 professionals across sales, marketing and strategic alliances. Notably, under Brendan's leadership, the revenue for the group grew to over $7 billion annually, representing a significant proportion of Celgene's global revenue. Prior to this role, Brendan held a series of other senior-level marketing roles at Celgene. Before coming to Celgene he was at Novartis for five years, serving in a number of U.S. and global marketing roles within the Company's oncology business unit. Over the course of his 22-year commercial career Brendan has been involved in the launch of nine new oncology products and indications.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --